NCT03583528 2025-06-13DOTATOC PET/CT for Imaging NET PatientsBritish Columbia Cancer AgencyActive not recruiting800 enrolled
NCT01794793 2024-10-01Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesRECORDATI GROUPPhase 4 Completed337 enrolled 8 charts
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled
NCT00020579 2012-03-15MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Completed75 enrolled